PL2661423T3 - Nowy sposób syntezy agomelatyny - Google Patents

Nowy sposób syntezy agomelatyny

Info

Publication number
PL2661423T3
PL2661423T3 PL12703857T PL12703857T PL2661423T3 PL 2661423 T3 PL2661423 T3 PL 2661423T3 PL 12703857 T PL12703857 T PL 12703857T PL 12703857 T PL12703857 T PL 12703857T PL 2661423 T3 PL2661423 T3 PL 2661423T3
Authority
PL
Poland
Prior art keywords
agomelatine
processs
synthesis
new
new processs
Prior art date
Application number
PL12703857T
Other languages
English (en)
Inventor
Samir Zard
Béatrice Sire
Mehdi Boumediene
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44121614&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2661423(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of PL2661423T3 publication Critical patent/PL2661423T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
PL12703857T 2011-01-05 2012-01-04 Nowy sposób syntezy agomelatyny PL2661423T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1100023A FR2970001B1 (fr) 2011-01-05 2011-01-05 Nouveau procede de synthese de l'agomelatine
EP12703857.8A EP2661423B1 (fr) 2011-01-05 2012-01-04 Nouveau procédé de synthèse de l'agomélatine
PCT/FR2012/000004 WO2012093225A1 (fr) 2011-01-05 2012-01-04 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
PL2661423T3 true PL2661423T3 (pl) 2015-07-31

Family

ID=44121614

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12703857T PL2661423T3 (pl) 2011-01-05 2012-01-04 Nowy sposób syntezy agomelatyny

Country Status (42)

Country Link
US (1) US8871975B2 (pl)
EP (1) EP2661423B1 (pl)
JP (1) JP5837615B2 (pl)
KR (1) KR101544129B1 (pl)
CN (1) CN103298779B (pl)
AP (1) AP3399A (pl)
AR (1) AR084779A1 (pl)
AU (1) AU2012204817B2 (pl)
BR (1) BR112013017264A2 (pl)
CA (1) CA2823584C (pl)
CL (1) CL2013001881A1 (pl)
CO (1) CO6731102A2 (pl)
CR (1) CR20130300A (pl)
CU (1) CU24291B1 (pl)
CY (1) CY1116366T1 (pl)
DK (1) DK2661423T3 (pl)
EA (1) EA024126B1 (pl)
ES (1) ES2539173T3 (pl)
FR (1) FR2970001B1 (pl)
GE (1) GEP201606576B (pl)
GT (1) GT201300176A (pl)
HR (1) HRP20150504T1 (pl)
IL (1) IL227282A (pl)
JO (1) JO3085B1 (pl)
ME (1) ME02109B (pl)
MX (1) MX2013007838A (pl)
MY (1) MY162973A (pl)
NI (1) NI201300061A (pl)
PE (1) PE20140169A1 (pl)
PH (1) PH12013501279A1 (pl)
PL (1) PL2661423T3 (pl)
PT (1) PT2661423E (pl)
RS (1) RS53958B1 (pl)
SA (1) SA112330135B1 (pl)
SG (1) SG191191A1 (pl)
SI (1) SI2661423T1 (pl)
TN (1) TN2013000273A1 (pl)
TW (1) TWI534127B (pl)
UA (1) UA104123C2 (pl)
UY (1) UY33847A (pl)
WO (1) WO2012093225A1 (pl)
ZA (1) ZA201305026B (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine
FR2934859B1 (fr) * 2008-08-05 2010-08-13 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
PE20140169A1 (es) 2014-02-15
CA2823584C (fr) 2015-09-01
JP2014509308A (ja) 2014-04-17
WO2012093225A1 (fr) 2012-07-12
RS53958B1 (sr) 2015-08-31
IL227282A (en) 2015-06-30
ES2539173T3 (es) 2015-06-26
TN2013000273A1 (fr) 2014-11-10
CN103298779B (zh) 2015-01-28
CA2823584A1 (fr) 2012-07-12
EP2661423B1 (fr) 2015-03-11
HK1189217A1 (en) 2014-05-30
SI2661423T1 (sl) 2015-10-30
UA104123C2 (uk) 2013-12-25
AP2013007024A0 (en) 2013-07-31
GT201300176A (es) 2014-12-30
BR112013017264A2 (pt) 2016-10-25
EP2661423A1 (fr) 2013-11-13
NI201300061A (es) 2013-12-11
JO3085B1 (ar) 2017-03-15
CO6731102A2 (es) 2013-08-15
AP3399A (en) 2015-08-31
PH12013501279A1 (en) 2021-06-02
MX2013007838A (es) 2013-09-06
ZA201305026B (en) 2014-03-26
US8871975B2 (en) 2014-10-28
CU20130087A7 (es) 2013-08-29
DK2661423T3 (da) 2015-06-22
US20130289308A1 (en) 2013-10-31
KR101544129B1 (ko) 2015-08-12
NZ612163A (en) 2015-09-25
SA112330135B1 (ar) 2014-08-31
IL227282A0 (en) 2013-09-30
MY162973A (en) 2017-07-31
AR084779A1 (es) 2013-06-26
FR2970001B1 (fr) 2013-01-04
CU24291B1 (es) 2017-12-08
UY33847A (es) 2012-07-31
CN103298779A (zh) 2013-09-11
EA024126B1 (ru) 2016-08-31
PT2661423E (pt) 2015-05-18
AU2012204817A1 (en) 2013-07-11
TW201309624A (zh) 2013-03-01
CY1116366T1 (el) 2017-02-08
CL2013001881A1 (es) 2013-12-06
FR2970001A1 (fr) 2012-07-06
KR20130115344A (ko) 2013-10-21
EA201300793A1 (ru) 2013-12-30
ME02109B (me) 2015-10-20
CR20130300A (es) 2013-08-09
TWI534127B (zh) 2016-05-21
AU2012204817B2 (en) 2015-08-27
GEP201606576B (en) 2016-11-25
SG191191A1 (en) 2013-07-31
HRP20150504T1 (hr) 2015-06-05
JP5837615B2 (ja) 2015-12-24

Similar Documents

Publication Publication Date Title
PL2531286T3 (pl) Sposób syntezy metanolu
PT2875062T (pt) Processo de síntese de poliarilétercetonas
IL222999A0 (en) Process for the preparation of pleuromutilins
IL220936A0 (en) Process for the synthesis of lacosamide
ZA201404440B (en) Process for the preparation of travoprost
SG11201400939YA (en) Process for the preparation of methoxymelonal
PT2723714T (pt) Novos processos para a preparação de amidas de prostaglandina
ZA201603457B (en) Novel method for the synthesis of agomelatine
AP3609A (en) New process for the synthesis of agomelatine
SI2661423T1 (sl) Novi postopek sinteze agomelatina
GB201111381D0 (en) Process for the synthesis of prodrugs of opioids
SI2739605T1 (sl) Postopek za pripravo kristalinične oblike i agomelatina
PL2710014T3 (pl) Sposób syntezy rifaksyminy
PL394565A1 (pl) Sposób otrzymywania niklowanych katalizatorów metanizacji
HUP1100291A2 (en) Process for the preparation of prostaglandin amides
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
GB201111386D0 (en) Process for the synthesis of prodrugs of opioids
GB201108370D0 (en) Product